ESR1 and breast carcinoma: As found over-expressed in human breast cancer cells and targeted by all forms of endocrine therapy, the zinc finger transcription factor ER is sensitive to either reversible or irreversible impairment after even brief exposures to various forms of oxidative stress [18].